IP Library › Granted Patent US 9,556,118
Granted Patent B2
US 9,556,118 · App. 14/323,492 · Granted Jan 31, 2017

Allosteric modulators of CB1 cannabinoid receptors

Inventors: Ganeshsingh A. Thakur (Cambridge, MA); Pushkar M. Kulkarni (Boston, MA)
Assignee: Northeastern University
C07D209/10C07D209/14C07D401/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,556,118
App. No.
14/323,492
Granted
Jan 31, 2017
Kind
B2
Abstract

The present invention relates to novel heterocyclic derivatives which are allosteric modulators of cannabinoid receptor 1 (CB1) and which are useful for the treatment or prevention of neurological and psychiatric disorders associated with endocannabinoid dysfunction and diseases in which the CB1 subtype of cannabinoid receptor is involved; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.

Claims (23)

1. A compound having the following structure, or a pharmaceutically acceptable salt thereof:

wherein Y 1 is C or N;

Z is NO 2 ;

each R 1 is independently H, halogen, OH, CN, (C 1 -C 6 )alkyl, or haloalkyl;

each R 2 is independently H, halogen, OH, or CN;

each R 3 is independently H, OH, CN, or piperdinyl;

m is 1-4; and

n is 1-5; provided the compound is not:

2. The compound of claim 1 , wherein the compound is a compound of structure (IC) and at least one R 2 is selected from the group consisting of Cl and F.

3. The compound of claim 1 , wherein the compound is a compound of structure (IC) and Y 1 is C.

4. A compound having a structure selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

5. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier or diluent and at least one compound having the following structure, or a pharmaceutically acceptable salt thereof:

wherein Y 1 is C or N;

Z is NO 2 ;

each R 1 is independently H, halogen, OH, CN, (C 1 -C 6 )alkyl, or haloalkyl;

each R 2 is independently H, halogen, OH, or CN;

each R 3 is independently H, OH, CN, or piperdinyl;

m is 1-4; and

n is 1-5; provided the compound is not:

6. The pharmaceutical composition of claim 5 , wherein the compound is a compound of structure (IC) and at least one R 2 is selected from the group consisting of Cl and F.

7. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier or diluent and at least one compound selected from the group consisting of:

or a pharmaceutically acceptable salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2014
From: THAKUR, GANESHSINGH A.; KULKARNI, PUSHKAR M.
To: NORTHEASTERN UNIVERSITY
Reel/Frame 033576/0941 →
Continuity (3)
Continuation PCTUS2013020543 · Jan 7, 2013
Provisional Application 61583380 · Jan 5, 2012
Related Publication 20150005346A1 · Jan 1, 2015